Profile
Dr. Aaron Ring is a President, Secretary, Treasurer & Director at Simcha Therapeutics, Inc., a President & Director at Seranova Bio LLC, a President & Director at Simcha Therapeutics Holding Co. LLC and a President, Chief Executive Officer & Director at Stipple Bio Inc. He is on the Board of Directors at Simcha Therapeutics, Inc., Seranova Bio LLC, Simcha Therapeutics Holding Co. LLC and Stipple Bio Inc.
Aaron Ring active positions
| Companies | Position | Start |
|---|---|---|
Simcha Therapeutics, Inc.
 Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Founder | 01/01/2018 |
Simcha Therapeutics Holding Co. LLC
 Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | President | - |
Seranova Bio LLC
 Seranova Bio LLC BiotechnologyHealth Technology Seranova Bio LLC, founded in 2020, is a company based in New Haven, CT that is focused on establishing a new paradigm for therapeutic target discovery. The company's Rapid Extracellular Antigen Profiling (REAP) platform combines high-quality, comprehensive protein sampling with next-generation DNA sequencing to profile patients' autoantibodies with higher throughput and fidelity than existing technologies. Seranova Bio's technological breakthrough reveals, in much greater depth, the underlying humoral response to disease and provides critical insights to drug developers. The company aims to collaborate with pharmaceutical partners to discover novel therapeutic targets and develop new treatments for autoimmune disease, neurodegeneration, and cancer. | President | - |
Stipple Bio Inc.
 Stipple Bio Inc. BiotechnologyHealth Technology Stipple Bio Inc. operates as a biotechnology company. The company is based in Milford, CT. The CEO of the company is Aaron Ring. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Simcha Therapeutics Holding Co. LLC
Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Health Technology |
Simcha Therapeutics, Inc.
Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Health Technology |
Seranova Bio LLC
Seranova Bio LLC BiotechnologyHealth Technology Seranova Bio LLC, founded in 2020, is a company based in New Haven, CT that is focused on establishing a new paradigm for therapeutic target discovery. The company's Rapid Extracellular Antigen Profiling (REAP) platform combines high-quality, comprehensive protein sampling with next-generation DNA sequencing to profile patients' autoantibodies with higher throughput and fidelity than existing technologies. Seranova Bio's technological breakthrough reveals, in much greater depth, the underlying humoral response to disease and provides critical insights to drug developers. The company aims to collaborate with pharmaceutical partners to discover novel therapeutic targets and develop new treatments for autoimmune disease, neurodegeneration, and cancer. | Health Technology |
Stipple Bio Inc.
Stipple Bio Inc. BiotechnologyHealth Technology Stipple Bio Inc. operates as a biotechnology company. The company is based in Milford, CT. The CEO of the company is Aaron Ring. | Health Technology |
- Stock Market
- Insiders
- Aaron Ring
